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INTRODUCTION
Anti-D immunization may cause hemolytic transfusion
reactions and hemolytic disease of the newborn. For the
transfusion recipient who has D-negative red blood cells
(RBC), D antigen-negative blood units should be given.
The frequency of D-negative varies widely among differ-
ent ethnic groups. Fifteen percent of Caucasian popula-
tions, 3 to 7 percent of African populations and only 0.5
percent of Chinese and Japanese populations are D-neg-
ative phenotype [1-4]. 
The D-negative frequency in Korean persons is 0.15
percent, about 1/100th of that in Caucasian individuals
[5]. Recently the molecular basis of D-negative in Korean
donors was characterized by two separate studies [6, 7].
Among Korean D-negative persons, nearly three-fourths
showed RHD total deletion, 13 to 16 percent had RHD (K-
409K) allele, and 9 to 10 percent had the RHD-CE-D hy-
brid form. RHD (K409K, 1227G>A) allelic variant, a sub-
stitution of the last nucleotide of exon 9 in RHDgene, has
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ti-D immunization in Asian population. Because the DEL phenotype can induce an anti-D immuniza-
tion in D-negative recipients, further discussion is needed whether RhD negative donors should be
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DEL phenotype and most DEL donors are typed as D-neg-
ative because routine serologic typing does not distinguish
D-negative from the DEL phenotype. According to the
national transfusion guidelines of many other countries,
RBCs from persons with the DEL phenotype are not dif-
ferentiated from truly D-negative and therefore are used
as D-negative blood for D-negative recipients. So far,
two cases of anti-D immunization by DEL red blood cells
have been reported in Austria and Japan [8, 9]. This report
describes a case of primary anti-D immunization induced
by transfusion of RBCs from a Korean donor with DEL
phenotype, carrying RHD (K409K) allele.
CASE REPORT
1. Immunohematology
A 68-yr-old group O, D-negative (ce) Korean man was
admitted to Dong-A University Hospital for operation of
atherosclerosis of abdominal aorta. He received 2 units of
crossmatch-compatible group O, D-negative RBC during
an aortobifemoral bypass surgery on February 21, 2008.
He had no history of prior transfusions or transplanta-
tions. Antibody screening test before the transfusion was
negative (ID-DiaCell I+II, DiaMed AG, Cressier, Morat,
Switzerland). Additionally, he received 2 units of cross-
match-compatible group O, D-negative RBC because of
low hemoglobin level on day 5 post-operation. On March
6, 2008, the antibody screening became positive and anti-
D was identified in the patient’s serum by gel technique
(ID-DiaPanel & ID-DiaPanel-P, DiaMed AG). The autol-
ogous control was negative. There was no evidence of acute
or delayed hemolytic transfusion reactions after those
transfusions and no remarkable changes in the levels of
hemoglobin, indirect bilirubin, and lactate dehydrogenase. 
The anti-D developed 9 days after last RBC transfusion
in the recipient was unexplained, so analytical checks for
errors including sample labeling, patient and donor units
identification as well as transfusion procedure were per-
formed. Indication of an error was not detected. He did
not receive Rh immunoglobulin. Forty days later the pati-
ent’s anti-D was persistently detected and showed simi-
lar strength of agglutination. 
2. Molecular biology
Stored blood samples transfused on Feb 26 were used
to confirm the status of RHD gene at the molecular level.
The blood samples transfused on Feb 21 were not avail-
able for molecular study because the documented inter-
val for storage of those samples was outdated. For these
2 units of RBC, we investigated RHD gene analysis using
plasma stored in Korean Red Cross. Informed consent was
obtained from the patient for the RHD genotype analysis. 
DNA was isolated from plasma or peripheral blood with
QIAamp blood mini kit (QIAGEN, Hilden, Germany). RHD
genes were determined by real-time PCR using the Light-
Cycler 2.0 (Roche, Penzberg, Germany). 
1) Detection of intron 4 and exon 7 by real-time PCR 
Plasma from 4 donors and peripheral blood from the
patient were examined for the presence of RHD-specific
polymorphisms located in RHD intron 4 and RHD exon 7
by real-time PCR and samples negative in these real-time
PCR tests were further tested for the RHDpromoter region
and RHD exon 10. Negative results were interpreted as
the complete deletion of RHD gene. The real-time PCR
procedures for RHD intron 4 and RHDexon 7 were as fol-
lows: 50 ng of DNA template mixed together with 2 μL LC
FastStart DNA Master SYBR Green I (Roche, Penzberg,
Germany), 0.4 μM each primer (Table 1), and 3.0 mM MgCl2
in a final volume of 20 μL. The following PCR program
was used: 10 min at 95℃ and 33 cycles of 5 sec at 95℃,
3 sec at 58℃, and 10 sec at 72℃. The program for ana-
lytical melting was 5 sec at 95℃ and 30 sec at 65℃ and
an increase to 99℃ at a 0.2℃ per second ramp rate. The
melting temperature (Tm) for intron 4 was 87.0±0.5℃
and that of exon 7 was 86.5±0.5℃. 
2) Detection of promoter region and exon 10 by real-time
PCR
The real-time PCR procedure for promoter region was
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as follows: 50 ng of DNA template mixed together with 2
μL LC FastStart DNA Master SYBR Green, 0.3 μM each
primer (Table 1), 1 μL 10% dimethyl sulfoxide (DMSO), and
3.0 mM MgCl2 in a final volume of 20 μL. The following
PCR program was used: 10 min at 95℃ and 33 cycles of
3 sec at 95℃, 2 sec at 60℃, and 10 sec at 72℃. The pro-
gram for analytical melting was 5 sec at 95℃ and 15 sec
at 65℃ and an increase to 99℃ at a 0.2℃ per second ramp
rate. The Tm for promoter region was 82.5±0.5℃. The
real-time PCR procedure for exon 10 was as follows: 50 ng
of DNA template mixed together with 2 μL LC FastStart
DNA Master SYBR Green I, 0.4 μM each primer (Table 1),
and 4.0 mM MgCl2 in a final volume of 20 μL. The follow-
ing PCR program was used: 10 min at 95℃ and 33 cycles
of 5 sec at 95℃, 5 sec at 60℃, and 10 sec at 72℃. The
program for analytical melting was 5 sec at 95℃ and 30
sec at 65℃ and an increase to 99℃ at a 0.2℃ per second
ramp rate. The Tm for exon 10 was 84.5±0.5℃. 
3) Detection of RHD (K409K) by real time PCR
A sample positive inRHDintron 4 and RHD exon 7 real-
time PCR was further investigated for RHD (K409K) by
real-time PCR. The real-time PCR procedure for RHD (K-
409K) was as follows: 50 ng of DNA template mixed toge-
ther with 2 μL LC FastStart DNA Master HybProbe 2 μL
(Roche, Penzberg, Germany), 0.3 μM each primer (Table
2), 0.3 μM each probe (Table 2), and 4.0 mM MgCl2 in a
final volume of 20 μL. The following PCR program was
used: 10 min at 95℃ and 40 cycles of 5 sec at 95℃, 10 secat
60℃, and 10 sec at 72℃. The program for analytical melt-
ing was 30 sec at 95℃ and 2 min at 40℃ and an increase
to 80℃ at a 0.4℃ per second ramp rate. The RHD (K409K)
variant was analyzed by lower Tm of 61.5±0.5℃ and wild
type with higher Tm of 66.5±0.5℃.
By real-time PCR analysis, one of four donors was found
to have RHD (K409K) and the patient and three donors
showed complete deletion of RHD gene. The blood posi-
tive for RHD (K409K) was transfused on February 26, 2008
and alloanti-D was detected after 9 days of transfusion. 
DISCUSSION
The Rh blood group is the second most clinically signif-
icant antigen of the blood group system in human. It also
is the most polymorphic of the blood groups with varia-
tions due to deletions or missense mutations. These molec-
ular variations lead to reduced antigen density [13]. DEL
is serologically designated as a quantitative variant of D
antigen. A small amount of anti-D can be eluted from DEL
red blood cells after incubation with anti-D, although there
is no agglutination by the indirect antiglobulin test proce-
dure of D typing. By molecular studies, DEL phenotype was
expressed by several different mutations such as RHD (M-
295I, 885G>T), RHD (K409K, 1227G>A), RHD (IVS3+1G>A),
RHD (IVS5-38del4), RHD (X418L), and RHD (delEx8) [8, 12,
14, 15]. These DEL variants can induce an alloanti-D in
D-negative recipients because most DEL donors are typed
as D-negative by serologic method. We could find two
reports of anti-D alloimmunization in D-negative recipi-
ents after the transfusion of DEL variants. A 67-yr-old
D-negative Japanese woman with a history of allosensi-
tization to D antigen developed a secondary alloanti-D
immunization induced by RHD (K409K) RBCs [9], and a 58-
yr-old D-negative Austrian woman developed a primary
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Name Genomic region Sequence (5′-3′) Reference
e4F Intron 4 CCTATTTTGGGCTGTACTGTGG [10]
Di4R Intron 4 GAACCTGCTCTGTGAAGTGCT [10]
De7F Exon 7 TGTTGTAACCGAGTGC [11]
De7R Exon 7 ACCATGCCATTGCCG [11]
PRM-F Promoter TCCACTTTCCACCTCCCTGC [12]
region
PRM-R Promoter GCAGCCAACTTCCCCTGTG [12]
region
De10-3F Exon 10 TAAGCAAAAGCATCCAA [11]
De10-3R Exon 10 ATGGTGAGATTCTCCT [11]
Table 1. Primers used for RHD gene real-time PCR
Name Reaction Sequence (5′-3′)
RHK409-F Primer AAAATATGGAAAGCACCTCATGA
RHK409-R Primer ATGGATTTGTTTCTCCTCTAGTT
RHK409-D Probe LC Red 640-ATCTTACCTTCCAGAAAA- 
CTTGGTCATCAA-Phosphate
RHK409-A Probe CATGCACTCAAAATCTATCACGTTAATA- 
GGTGAA-fluorescein
Table 2. Primers and probes for real-time PCR to detect the
RHD (K409K) 
alloanti-D by another DEL variant, RHD (IVS5-38del4) [8].
In our case, interestingly, a 68-yr-old D-negative Kore-
an man developed a primary alloanti-D by RHD (K409K)
RBCs.
The molecular basis of D-negative is different among
different ethnic populations. Most of D-negative Cauca-
sian populations have complete RHD deletion but popu-
lations from China, Japan, and Korea have rather diverse
mutation variants. The frequency of RHD (K409K, 1227G>
A) allele in apparent D-negative Korean donors is about
13 to 16 percent, which is the most prevalent mutation
variant for DEL phenotype in Korea [6, 7]. Recently, Tai-
wan researchers developed a real-time PCR-melting curve
analysis to detect a nucleotide change at 1227 position of
RHD exon 9. Since almost all the DEL type in East Asians
have the characteristic 1227A mutation, this real-time
PCR method for single nucleotide polymorphism showed
high sensitivity (100%) and high specificity (98.75%) [16].
The routine RHD genotyping in donor screening pro-
gram was adopted in Germany and Upper Austria. Sam-
ples of first-time D-negative donors by serology were
tested in pools of 20 for the RHD-specific polymorphic
sites by PCR but the target sites of RHD gene were dif-
ferent in each country. Within 6 yr of testing, the preva-
lence of RHD gene carriers detected was 0.21 percent and
DEL phenotype was approximately one-half of the RHD
gene carriers in Germany. Ninety-four samples of 23,330
pretyped D-negative samples carried at least one RHD
marker in Upper Austria. These two studies suggested
that the integration of RHDgenotyping into routine screen-
ing was practical and it would be necessary to adapt a
proper RHD genotyping strategy in each population [17,
18]. Our report is the first case in which DEL RBCs with
RHD (K409K) induced a primary alloanti-D immunization
in Asian population. Because the DEL phenotype can in-
duce an anti-D immunization in D-negative recipients,
further discussion is needed whether D-negative donors
should be screened by molecular method and what an
efficient genotyping method is for detecting the RHDgene
carriers in Korea.
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